跳至主要内容
临床试验/JPRN-jRCT2013190001
JPRN-jRCT2013190001招募中未知

ong-term follow-up study of patients who have previouslybeen exposed to UCART19 (allogeneic engineered T-cellsexpressing a lentiviral-based anti-CD19 chimeric antigenreceptor) - LTFU study

clinical operation department International center for therapeutic research0 个研究点目标入组 200 人开始时间: 2019年4月28日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • All patients dosed with UCART19 must be enrolled in the long-term follow up study after the completion of the parent study.

排除标准

  • No exclusion criteria for this study.

研究者

发起方
clinical operation department International center for therapeutic research

相似试验

进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864
EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864
EUCTR2016-000297-38-FRInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0 Level: LLT Classification code 10060390 Term: Leukaemia lymphoblastic acute System Organ Class: 100000004864
EUCTR2016-000297-38-ESInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19 or ALLO-501Advanced lymphoid malignanciesMedDRA version: 21.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10008958Term: Chronic lymphocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2016-000297-38-GBInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中(未招募)
1 期
ong-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors.
CTIS2024-511684-28-00Autolus Limited111